Evidence map›Paper›PMID 31671666›Full record

ArticleCancers2019

Automated Workflow for Somatic and Germline Next Generation Sequencing Analysis in Routine Clinical Cancer Diagnostics.

Lucia Anna Muscarella, Federico Pio Fabrizio, Maria De Bonis, Maria Teresa Mancini, Teresa Balsamo, Paolo Graziano, Flavia Centra, Angelo Sparaneo, Domenico Trombetta, Antonio Bonfitto and 4 more

Abstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Cutting-edge technology and automation in the pathology laboratory.Virchows Archiv : an international journal of pathology · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lucia Anna MuscarellaLaboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. l.muscarella@operapadrepio.it.
Federico Pio FabrizioLaboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. fp.fabrizio@operapadrepio.it.
Maria De BonisDepartment of Laboratory Medicine of the 'Agostino Gemelli' Foundation in Rome, 00168 Rome, Italy. mari.debonis86@gmail.com.
Maria Teresa ManciniMASMEC S.p.A, 70026 Modugno, (BA), Italy. mariateresa.mancini@masmec.com.
Teresa BalsamoLaboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. t.balsamo@operapadrepio.it.
Paolo GrazianoUnit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. p.graziano@operapadrepio.it.
Flavia CentraLaboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. f.centra@operapadrepio.it.
Angelo SparaneoLaboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. a.sparaneo@operapadrepio.it.
Domenico TrombettaLaboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. d.trombetta@operapadrepio.it.
Antonio BonfittoUnit of Pathology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. antonio.bonfitto@operapadrepio.it.
Vito ScagliusiMASMEC S.p.A, 70026 Modugno, (BA), Italy. vito.scagliusi@masmec.com.
Pietro LarizzaMASMEC S.p.A, 70026 Modugno, (BA), Italy. piero.larizza@masmec.com.
Ettore Domenico CapoluongoDepartment of Molecular Medicine and Medical Biotechnologies, University Federico II-CEINGE, 80145 Naples, Italy. capoluongo@ceinge.unina.it.
Vito Michele FazioLaboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, (FG), Italy. FAZIO@unicampus.it.

Funding

Associazione Italiana per la Ricerca sul Cancro 12983Ministero della Salute Ricerca Corrente 2019Regione Puglia MTJU9H8
6 · The paper itself

Abstract

Thanks to personalized medicine trends and collaborations between industry, clinical research groups and regulatory agencies, next generation sequencing (NGS) is turning into a common practice faster than one could have originally expected. When considering clinical applications of NGS in oncology, a rapid workflow for DNA extraction from formalin-fixed paraffin-embedded (FFPE) tissue samples, as well as producing high quality library preparation, can be real challenges. Here we consider these targets and how applying effective automation technology to NGS workflows may help improve yield, timing and quality-control. We firstly evaluated DNA recovery from archived FFPE blocks from three different manual extraction methods and two automated extraction workstations. The workflow was then implemented to somatic (lung/colon panel) and germline (

Indexed as

automationDNA extractionFFPElibrary preparationNGS.

Identifiers

PMID31671666
PMCPMC6896097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.